Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveBiomarkers and the prediction of atrial fibrillation: state of the artThe Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio MirrorCognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?Inflammation and C-reactive protein in atrial fibrillation: cause or effect?Mendelian randomization studies: a review of the approaches used and the quality of reportingAtrial Fibrillation: The Science behind Its DefianceCausal diagrams in systems epidemiologyScarcity of atrial fibrillation in a traditional African population: a community-based study.A Circulating Biomarker Risk-Prediction Model Correlates with CHADS-2 Risk Score in Chronic Atrial Fibrillation.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Cancer risk by combined levels of YKL-40 and C-reactive protein in the general populationRole of inflammation in atrial fibrillation pathophysiology and management.Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC StudyRisk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study.Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.Prevalence and Risk Factors of Atrial Fibrillation in Chinese Elderly: Results from the Chinese Longitudinal Healthy Longevity Survey.Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammationA polymorphism associated with increased levels of YKL-40 and the risk of early onset of lone atrial fibrillation.C-Reactive Protein Gene Polymorphisms and the Risk of Atrial Fibrillation in a Chinese Population in Taiwan.A significant causal association between C-reactive protein levels and schizophreniaAtrial Fibrillation on Intensive Care Unit Admission Independently Increases the Risk of Weaning Failure in Nonheart Failure Mechanically Ventilated Patients in a Medical Intensive Care Unit: A Retrospective Case-Control StudyCirculating Biomarkers Predictive of Postoperative Atrial Fibrillation.Mechanisms And Management Of Thrombo-Embolism In Atrial FibrillationDiabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and InterventionsDiagram-based Analysis of Causal Systems (DACS): elucidating inter-relationships between determinants of acute lower respiratory infections among children in sub-Saharan Africa.Biomarkers in atrial fibrillation: a clinical review.Inflammation and the pathogenesis of atrial fibrillation.Prognostic factors of clinical endpoints in elderly patients with atrial fibrillation during a 2-year follow-up in China: An observational cohort study.Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study.Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study.A functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation.Neopterin and interleukin-6 as predictors of recurrent atrial fibrillation.Inflammation as Possible Mediator for the Relationship Between Lung and Arterial Function.Risk factors responsible for atrial fibrillation development between symptomatic patients with concealed or manifest atrioventricular accessory pathways.Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study.Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study.Obese hypertensive men have plasma concentrations of C-reactive protein similar to that of obese normotensive men.
P2860
Q24594814-A2C7D671-EE62-463A-BBAE-9EF68EC73BBEQ26739847-583EAAA2-54C3-4A1B-8BDD-525B68E86804Q26742118-12447CE2-8D19-4537-AFC7-94701FBC93AEQ26799394-396A8144-72FA-4C09-81CB-0AA9C747544AQ26865381-A1FFABAD-7FFE-4415-89EA-05145CBBEF5BQ26999349-2A5E91D7-EB84-4863-B6FF-5536C1DB3A94Q28072139-04CA691C-874C-4A3F-86C6-C293562066DAQ30395155-D24D4CFA-77CC-4033-96B2-FF433E8147ACQ33936957-904D401F-8AC7-4320-86B9-831D90618081Q35105438-537EEE4B-F03A-444C-8F2C-3B23C3173B85Q35609742-7A5C8A1A-4A89-486B-A803-B7CD76617971Q35653750-18B09396-AC6F-4BB6-B906-EC6427454315Q35688023-47DF4D16-CB30-4967-9B23-77DCB2E07E53Q35913178-ECE6BBD2-AFC5-4AC5-BE3B-F0D000D81537Q36178661-82AB13A6-ABA5-4BF0-8DB9-66FC7D49C0ABQ36382360-031B98A0-F4A2-4327-ABFD-F17E6F311CBAQ36498499-3B1A4556-90C2-44E8-9A68-33CA7CEE1775Q36514164-ECA6BBA3-A09F-45C5-A435-6D5F3DAC69B3Q36560782-24BD426D-8A2D-419F-B4F6-1E5AA5641FD3Q36721318-DBE65E85-7CD0-404D-9DD1-6391AF74D38DQ36914697-78CC7F87-96D0-4D2A-9026-61A49A1DC33DQ36993220-155BBB66-1C2D-421B-940A-FAAF483FEFB5Q37094015-ADD1FC60-AD9A-4339-92A2-6DDB38C51CBBQ37115524-70D66B19-538F-4BD9-835C-3796A8B5F96AQ37496314-DF79C185-4B53-45E6-B49C-FC230D6BFCE1Q37524760-05374BEB-7F3A-4E6A-B107-1ACEA5EA06A5Q38079565-373569F7-1C6C-4E56-861E-3A042647C607Q38333088-0C30B0CD-F4AA-4882-9670-571FC91FA32DQ38620315-633A523F-62AB-4339-962E-CDB8681223EEQ38738095-09AB2484-4216-4599-B3B4-D6132E187202Q38789345-9650B8F2-038A-4910-8D5E-3F1E8E567E55Q38951011-46BD3338-ADA7-4609-9B23-17E68B55553CQ39357608-CBB44A1D-079E-438A-8955-9DD15BB540B6Q39653047-0A7C463E-ABA2-48D6-BC20-ACAB61DE2355Q39897313-6390A5AC-B07F-4841-9BD4-6EFD4F8DE530Q40494922-D021A771-FB2D-44FA-A279-886CA70D0D3EQ40964057-B8E5E233-8AD5-42C2-8808-24C7CAC83F94Q43543562-1AD2DC42-15F2-4954-9705-C4D41E0F13A2Q44516862-7AD926AB-2DFE-4EA5-BA17-0AE658F19BE3Q46438151-5B21E8C2-8FFB-4466-9B2D-77869DACFD73
P2860
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
description
im August 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2010
@uk
name
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
@en
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
@nl
type
label
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
@en
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
@nl
prefLabel
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
@en
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
@nl
P2093
P50
P1476
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
@en
P2093
Gorm B. Jensen
Jens Friberg
Jeppe Zacho
Sarah C.W. Marott
P304
P356
10.1016/J.JACC.2010.02.066
P407
P577
2010-08-01T00:00:00Z